Sign in

CIK 0001160308

  • Non-accelerated filer
  • Smaller reporting company
Ticker
SVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841318182
Phone
+51 285113796
Business address
6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
Former names
Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-15 Hawkins Richard J Director Sale −10,409 $11.16 $116K 0
2019-05-14 Hawkins Richard J Director Exercise or conversion +21,682 $0.52 $11K 21,682
2019-05-14 Hawkins Richard J Director Exercise or conversion +586 $0.52 $305 22,268
2019-05-14 Hawkins Richard J Director Exercise or conversion +2,288 $0.52 $1K 24,556
2019-05-14 Hawkins Richard J Director Exercise or conversion +444 $0.55 $244 25,000
2019-05-14 Hawkins Richard J Director Sale −14,591 $11.07 $161K 10,409
2019-05-14 Hawkins Richard J Director Exercise or conversion · Stock Option (Right to Buy) −21,682 0
2019-05-14 Hawkins Richard J Director Exercise or conversion · Stock Option (Right to Buy) −586 0
2019-05-14 Hawkins Richard J Director Exercise or conversion · Stock Option (Right to Buy) −2,288 0
2019-05-14 Hawkins Richard J Director Exercise or conversion · Stock Option (Right to Buy) −444 728
2019-05-02 Lowrance David L Chief Financial Officer Exercise or conversion +3,700 $1.51 $6K 3,700
2019-05-02 Lowrance David L Chief Financial Officer Sale −3,700 $10.82 $40K 0
2019-05-02 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −3,700 80,684
2019-05-01 Lowrance David L Chief Financial Officer Exercise or conversion +3,800 $1.51 $6K 3,800
2019-05-01 Lowrance David L Chief Financial Officer Sale −3,800 $10.76 $41K 0
2019-05-01 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −3,800 84,384
2019-04-08 Lowrance David L Chief Financial Officer Exercise or conversion +4,734 $1.51 $7K 4,734
2019-04-08 Lowrance David L Chief Financial Officer Sale −4,734 $9.04 $43K 0
2019-04-08 Lowrance David L Chief Financial Officer Exercise or conversion · Employee Stock Option (right to buy) −4,734 88,184
2019-04-08 Jouhikainen Jaakko Taneli President and COO Sale −16,336 $9.04 $148K 167,569

Page 16 of 20 · 390 trades